Search results for: "Novo Nordisk"

(283 records)

You need to be a subscriber to read this article.
Click here to find out more.
Packaging
Avoiding glass delamination

Avoiding glass delamination

Contamination with glass flakes caused by delamination of the internal finish of container closure systems or prefilled syringes has caused numerous drug recalls. Surface...
Regulatory
Novo Nordisk gains EU approval for FlexTouch

Novo Nordisk gains EU approval for FlexTouch

Danish firm\'s latest innovation within prefilled insulin pens
Manufacturing
Novo Nordisk to invest DKK1bn in new plant

Novo Nordisk to invest DKK1bn in new plant

For the production of haemophilia and growth hormone biopharmaceuticals in Kalundborg, Denmark

Patent applications published 16 March 2011

Selected patent applications from the weekly European Patents Bulletin
Ingredients
Improving oral drug delivery

Improving oral drug delivery

Poor permeability of pharmaceutical actives prevents many drugs from reaching the market. David Gschneidner, Emisphere Technologies, highlights a technology that can improve...

Novo Nordisk reports strong sales growth

Led by new diabetes drug Victoza and modern insulins

Patent applications published 5 January 2011

Selected patent applications from the weekly European Patents Bulletin
Drug Delivery
NovoPen Echo wins Good Design Award

NovoPen Echo wins Good Design Award

Injection pen for diabetes has been designed specially for children

Novo Nordisk to appeal against Prandin ruling

US court says patent is unenforceable

Sanofi appoints quartet of managers for emerging markets

Will serve in Eurasia, Asia, Latin America and Japan & Pacific

Novo Nordisk buys rights to Eligen technology

For oral formulations of insulin for treating diabetes

Patent applications published 3 November 2010

Selected patent applications from the weekly European Patents Bulletin

Patent applications published 8 September 2010

Selected patent applications from the weekly European Patents Bulletin

Novo Nordisk to double r&d staff at centre in China

Expansion will focus mainly on diabetes research

Novo Nordisk sells ZymoGenetics shares to B-MS

Transaction has been unanimously approved by both boards of directors

Patent applications published 30 June 2010

Selected patent applications from the weekly European Patents Bulletin

Trending Articles

  1. Nicox’s NCX 470 new drug application submitted in the United States by Kowa The submission is based on positive results from two Phase III clinical trials (Mont Blanc and Denali)
  2. Thermo Fisher's Patheon becomes exclusive third-party CDMO for KinetiSol technology The agreement will install KinetiSol Formulator equipment across Patheon's Bend and Cincinnati OSD sites, offering pharma customers an integrated development-to-commercial pathway for poorly soluble drug candidates
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Annex 1 at the transfer point: how to meet the evolving evidence challenge As Annex 1 raises expectations for contamination control, transfer-point evidence must become more dynamic, connected and defensible throughout the entire product lifecycle
  4. Sanofi offers EU commitments for flu vaccine disparagement claims Sanofi has proposed remedies to EU antitrust regulators after allegations it disparaged rival CSL Seqirus's Fluad vaccine in Germany and France since 2024
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Back to basics: a simple guide to checkweighing in pharmaceutical production Mettler-Toledo’s Miriam Krechlok tells Dr Kevin Robinson how checkweighing helps pharmaceutical manufacturers to verify product completeness, control fill levels and maintain compliance, safety and efficiency

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Digital The AI-driven biotech and China Medical System have struck a second collaboration in three months, targeting a mass-market CNS indication via a novel mechanism identified by...
Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

Read more
Research & Development The global study builds on US POINTER trial findings, testing whether adding a metabolism-targeting drug to structured lifestyle programmes can further reduce cognitive decline...
Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Read more
Manufacturing Piramal Pharma Limited (PPL) (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a...
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Read more
Manufacturing The FDA's pre-licence inspection approval of WuXi Biologics' MFG8 facility will strengthen the CRDMO's commercial manufacturing network, supporting the global supply of a...
WuXi Biologics' Hebei facility secures FDA PLI approval for commercial autoimmune biologics manufacturing

WuXi Biologics' Hebei facility secures FDA PLI approval for commercial autoimmune biologics manufacturing

Read more
Manufacturing Boehringer Ingelheim has selected the osapiens HUB for Mobile Maintenance for its global, regulated manufacturing operations
Boehringer Ingelheim standardises plant maintenance globally with osapiens

Boehringer Ingelheim standardises plant maintenance globally with osapiens

Read more
Manufacturing With throughput up to 100 kg/h, the new twin-screw extruder brings lab-grade process understanding into pilot-scale production, enabling users to validate process parameters...
Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight

Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight

Read more
Dosage Forms While injection pens and weight-loss pills are gaining ground across the Western world, the debate focuses one-sidedly on the kilos and not on the body’s health and the...
Obesity medication: fast results … but at the expense of long-term health

Obesity medication: fast results … but at the expense of long-term health

Read more
Pharmaceutical The agreement will expand Teva’s biosimilars pipeline, with the company securing exclusive commercialisation rights for Polpharma Biologics’ proposed ocrelizumab biosimilar...
Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate

Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate

Read more